TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 47 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 150 | +200.0% | 0.00% | – |
| Q3 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 50 | -66.7% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 150 | -99.4% | 0.00% | – |
| Q2 2017 | $47,000 | +161.1% | 24,676 | +341.7% | 0.00% | – |
| Q1 2017 | $18,000 | +1700.0% | 5,587 | +1478.2% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 354 | +200.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |